Susanna S. Ng

Nathan, QLD, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications

Longitudinal spatial neutrophil profiling during ACT in murine melanoma reveals distinct lymph node infiltration patterns.

Longitudinal spatial neutrophil profiling during ACT in murine melanoma reveals distinct lymph node infiltration patterns.

Journal: NPJ systems biology and applications
Published: February 25, 2026

NKG7 is a Stable Marker of Cytotoxicity Across Immune Contexts and Within the Tumor Microenvironment.

NKG7 is a Stable Marker of Cytotoxicity Across Immune Contexts and Within the Tumor Microenvironment.

Journal: European journal of immunology
Published: February 15, 2025

Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical note.

Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical note.

Journal: PloS one
Published: November 11, 2024

The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

Journal: Molecular cancer therapeutics
Published: October 28, 2024

Expression of the large amino acid transporter SLC7A5/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinoma.

Expression of the large amino acid transporter SLC7A5/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinoma.

Journal: Human pathology
Published: July 25, 2024

Type I Interferon Drives a Cellular State Inert to TCR-Stimulation and Could Impede Effective T-Cell Differentiation in Cancer.

Type I Interferon Drives a Cellular State Inert to TCR-Stimulation and Could Impede Effective T-Cell Differentiation in Cancer.

Journal: European journal of immunology
Published: July 09, 2024

Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.

Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.

Journal: Nature immunology
Published: March 22, 2024

Clonally expanded, targetable, natural killer-like NKG7 T cells seed the aged spinal cord to disrupt myeloid-dependent wound healing.

Clonally expanded, targetable, natural killer-like NKG7 T cells seed the aged spinal cord to disrupt myeloid-dependent wound healing.

Journal: Neuron
Published: March 19, 2024

Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Journal: Nature immunology
Published: February 15, 2024

IL-10-producing Th1 cells possess a distinct molecular signature in malaria.

IL-10-producing Th1 cells possess a distinct molecular signature in malaria.

Journal: The Journal of clinical investigation
Published: February 14, 2023

STING activation promotes autologous type I interferon-dependent development of type 1 regulatory T cells during malaria.

STING activation promotes autologous type I interferon-dependent development of type 1 regulatory T cells during malaria.

Journal: The Journal of clinical investigation
Published: February 03, 2023

A molecular signature for IL-10-producing Th1 cells in protozoan parasitic diseases.

A molecular signature for IL-10-producing Th1 cells in protozoan parasitic diseases.

Journal: JCI insight
Published: February 01, 2023
Showing 1-12 of 66

Last Updated: 09/26/2026